IJMABHR International Journal of Medical and All Body Health ResearchIJMABHR 2582-8940 Anfo Publication House 385 Lactobacillus Probiotics: Mechanisms, Health Benefits, and Applications in Combating Pathogenic Bacteria HassanMohamed Younes A GaballaMahmoud F ZIDANMohamed Eid Kotb AbidAlaa Alrahman DM AttitallaIdress Hamad Department of Microbiology, Faculty of Science, Omar Al-Mukhtar, University AL-Bayda, Libya Director of the General Administration of Occupational Safety and Health, Saudi Arabia Chemist at Al khorayef Water and Energy Technology Company Al-Ahsa, Saudi Arabia 13082025 6 3 208 216 02072025 01082025 CC BY-NC-SA 4.0

This research paper explores the potential of Lactobacillus probiotics as a safe and cost-effective alternative to conventional antibiotics for combating antibiotic-resistant pathogenic bacteria. With the rise of multidrug-resistant pathogens posing a significant threat to global health, there is an urgent need for innovative therapeutic strategies. Probiotics, particularly lactic acid bacteria such as Lactobacillus, offer promising health benefits, including enhancing gut microbiota balance, strengthening immune responses, and producing antimicrobial compounds that inhibit pathogenic bacteria. The study highlights the mechanisms by which Lactobacillus strains exert their beneficial effects, such as competitive exclusion of pathogens, production of bacteriocins, modulation of gut barrier function, and immunomodulation. Additionally, probiotics demonstrate efficacy in treating gastrointestinal disorders, metabolic imbalances, and even chronic conditions like cancer and mental health disorders. Beyond human health, their applications extend to agriculture, where they contribute to sustainable practices by improving plant resilience and soil health. Despite these advantages, further research is needed to optimize strain-specific effects, dosages, and long-term impacts. Collaborative efforts among researchers, clinicians, and policymakers are essential to integrate probiotics into mainstream healthcare and environmental management. Embracing probiotics as part of daily nutrition and therapeutic regimens could revolutionize public health, reduce reliance on antibiotics, and promote ecological sustainability. In conclusion, Lactobacillus and other probiotic bacteria represent a bridge between natural microbial solutions and modern medicine, offering innovative approaches to address global health challenges while aligning with sustainable practices. Continued exploration of their potential promises to unlock new avenues for improving health across diverse ecosystems. 

 LactobacillusProbioticsAntibiotic ResistanceGut MicrobiotaAntimicrobial MechanismsHealth Benefits References Papajk J, Mezerová K, Uvízl R, Štosová T, Kolář M. Clonal diversity of Klebsiella spp. and Escherichia spp. strains isolated from patients with ventilator-associated pneumonia. Antibiotics. 2021;10(6):674. doi:10.3390/antibiotics10060674. Hricová K, Štosová T, Kučová P, Fišerová K, Bardoň J, Kolář M. Analysis of vancomycin-resistant enterococci in hemato-oncological patients. Antibiotics. 2020;9(11):785. doi:10.3390/antibiotics9110785. Kollef MH, Bassetti M, Francois B, Burnham J, Dimopoulos G, Garnacho-Montero J, et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med. 2017;43:1187–1197. doi:10.1007/s00134-017-4682-7. FAO/WHO. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001. Available from: https://www.fao.org/3/a0512e/a0512e.pdf Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi:10.1038/nrgastro.2014.66. Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649–667. doi:10.1038/s41575-021-00440-6. Liévin-Le Moal V, Servin AL. Anti-infective activities of Lactobacillus strains in the human intestinal microbiota: From probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev. 2014;27(2):167–199. doi:10.1128/CMR.00080-13. Di Cerbo A, Palmieri B, Aponte M, Morales-Medina JC, Iannitti T. Mechanisms and therapeutic effectiveness of Lactobacillus. J Clin Pathol. 2016;69(3):187–203. doi:10.1136/jclinpath-2015-202976. Herkel T, Uvizl R, Doubravska L, Adamus M, Gabrhelik T, Htoutou Sedlakova M, et al. Epidemiology of hospital-acquired pneumonia: Results of a Central European multicenter, prospective, observational study compared with data from the European region. Biomed Pap. 2016;160(3):448–455. doi:10.5507/bp.2016.014. Arnan M, Gudiol C, Calatayud L, Liñares J, Dominguez MÁ, Batlle M, et al. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis. 2011;30(3):355–360. doi:10.1007/s10096-010-1093-x. Abd El-Gawad IA, El-Sayed EM, Hafez SA, El-Zeini HM, Saleh FA. The hypocholesterolaemic effect of milk yoghurt and soy-yoghurt containing Bifidobacteria in rats fed on a cholesterol-enriched diet. Int Dairy J. 2005;15(1):37–44. doi:10.1016/j.idairyj.2004.06.001. Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A. The effect of a probiotic milk product on plasma cholesterol: A meta-analysis of short-term intervention studies. Eur J Clin Nutr. 2000;54(11):856–860. doi:10.1038/sj.ejcn.1601104. Aloha AJ, Yli-Knuuttila H, Suomalainen T, Poussa T, Ahlstrom A, Meurman JH. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol. 2002;47(11):799– 804. doi:10.1016/S0003-9969(02)00112-7. Arora M, Sharma S, Baldi A. Comparative insight of regulatory guidelines for probiotics in USA, India and Malaysia: A critical review. Int J Biotechnol Wellness Ind. 2013;2(2):51–64. Arseneault-Breard J, Rondeau I, Gilbert K, Girard SA, Tompkins TA, Godbout R, et al. Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br J Nutr. 2012;107(12):1793–1799. doi:10.1017/S0007114511005137. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007;61(3):355–361. doi:10.1038/sj.ejcn.1602546. Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011;23(12):1132–1139. doi:10.1111/j.1365 -2982.2011.01796.x. International Journal of Medical and All Body Health Research www.allmedicaljournal.com Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050–16055. doi:10.1073/pnas.1102999108. Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol. 2006;100(4):754–765. doi:10.1111/j.1365-2672.2006.02837.x. Chen LJ, Tsai HT, Chen WJ, Hsieh CY, Wang PC, Chen CS, et al. in vitro antagonistic growth effects of Lactobacillus fermentum and Lactobacillus salivarius and their fermentative broth on periodontal pathogens. Braz J Microbiol. 2012;43(4):1376–1384. doi:10.1590/S1517-83822012000400019. Chen YP, Hsiao PJ, Hong WS, Dai TY, Chen MJ. Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vitro. J Dairy Sci. 2011;95(1):63–74. doi:10.3168/jds.2011-4696. Cildar SK, Germec D, Sandalli N, Ozdemir FI, Arun T, Twetman S, et al. Reduction of salivary mutans streptococci in orthodontic patients during daily consumption of yoghurt containing probiotic bacteria. Eur J Orthod. 2009;31(4):407–411. doi:10.1093/ejo/cjn108. Cryan JF, Dinan TG. Mind-altering microorganisms: The impact of the gut microbiota on brain and behavior. Nat Rev Neurosci. 2012;13(10):701–712. doi:10.1038/nrn3346. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2009;43(2):164–174. doi:10.1016/j.jpsychires.2008.03.009. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010;170(4):1179–1188. doi:10.1016/j.neuroscience.2010.08.005. Duary RK, Bhausaheb MA, Batish VK, Grover G. Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol Biol Rep. 2011;39(4):4765– 4775. doi:10.1007/s11033-011-1269-1. Elgert KD. Immunology: Understanding the Immune System. 2 nd ed. New Jersey: Wiley-Blackwell; 2009. p. 285–292. Emms S, Sia. Malaysia’s markets for functional foods, nutraceuticals and organic foods: An introduction for Canadian producers and exporters. Agriculture and Agri-Food Canada. 2011. Available from: http://www.atssea.agr.gc.ca/ase/pdf/5842-eng.pdf European Food Safety Authority (EFSA). Opinion of the scientific committee on introduction of a qualified presumption of safety (QPS) approach for assessment of selected microorganisms referred to EFSA. EFSA J. 2007;5(12):1–16. Foligné B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S, et al. Correlation between in vitro and in vitro immunomodulatory properties of lactic acid bacteria. World J Gastroenterol. 2007;13(2):236– 243. doi:10.3748/wjg.v13.i2.236. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO). Report of a Joint FAO/WHO Working Group on drafting guidelines for the evaluation of probiotics in food. 2002. Available from: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf Forssten SD, Lahtinen SJ, Arthur C, Ouwehand AC. The intestinal microbiota and probiotics. In: Malago JJ, Koninkx JFJ, Marinsek-Logar R, editors. Probiotic Bacteria and Enteric Infections. New York: Springer; 2011. p. 11–24. doi:10.1007/978-94-007-0386-5_2. Ganguli K, Meng D, Rautava S, Lu L, Walker WA, Nanthakumar N. Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am J Physiol Gastrointest Liver Physiol. 2013;304(2):G132– G141. doi:10.1152/ajpgi.00142.2012. Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2:94. doi:10.3389/fphys.2011.00094. Gueniche A, Bastien P, Ovigne JM, Kermici M, Courchay G, Chevalier V, et al. Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp Dermatol. 2010;19(8):e1–e8. doi:10.1111/j.1600-0625.2009.00932.x. Haukioja A, Loimaranta V, Tenovuo J. Probiotic bacteria affect the composition of salivary pellicle and streptococcal adhesion in vitro. Oral Microbiol Immunol. 2008;23(4):336–343. doi:10.1111/j.1399-302X.2008.00435.x. Hojo K, Mizoguchi C, Takemoto N, Oshima T, Gomi K, Arai T. Distribution of salivary Lactobacillus and Bifidobacterium species in periodontal health and disease. Biosci Biotechnol Biochem. 2007;71(1):152– 157. doi:10.1271/bbb.60420. Iordache F, Iordache C, Chifiriuc MC, Bleotu C, Pavel M, Smarandache D, et al. Antimicrobial and immunomodulatory activity of some probiotic fractions with potential clinical application. Archiva Zootechnica. 2008;11(3):41–51. Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr. 2001;73(2):465–470. Ishikawa H, Aiba Y, Nakanishi M, Oh-Hashi Y, Koga Y. Suppression of periodontal pathogenic bacteria in the saliva of human by the administration of Lactobacillus salivarius T12711. J Jpn Soc Periodontol. 2003;45(1):105–112. doi:10.2329/perio.45.105. Jensen ME, Wefel JS. Effects of processed cheese on human plaque pH and demineralization and remineralization. Am J Dent. 1990;3(5):217–223. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol. 2000;78(1):80–88. doi:10.1046/j.1440-1711.2000.00886.x. Kang MS, Kim BG, Chung J, Lee HC, Oh JS. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. J Clin Periodontol. 2006;33(3):226–232. doi:10.1111/j.1600-051X.2006.00893.x. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. International Journal of Medical and All Body Health Research www.allmedicaljournal.com 2011;474(7351):307–317. doi:10.1038/nature10209. Koll-Klais P, Mandar R, Leibur E, Marcotte H, Hammarstrom L, Mikelsaar M. Oral Lactobacillus in chronic periodontitis and periodontal health: Species composition and antimicrobial activity. Oral Microbiol Immunol. 2005;20(6):354–361. doi:10.1111/j.1399-302X.2005.00239.x. Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J. 2006;30(2):55–60. Kumar R, Grover S, Batish VK. Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague–Dawley rats. Br J Nutr. 2011;105(4):561–573. doi:10.1017/S0007114510003740. Lakhan SE, Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutr Metab. 2010;7:79. doi:10.1186/1743-7075-7-79. Lambert JM, Bongers RS, de Vos WM, Kleerebezem M. Functional analysis of four bile salt hydrolase and penicillin acylase family members in Lactobacillus plantarum WCFS1. Appl Environ Microbiol. 2008;74(15):4719–4726. doi:10.1128/AEM.00137-08. Leuschner RGK, Robinson TP, Hugas M, Cocconcelli PS, Richard-Forget F, Klein G, et al. Qualified presumption of safety (QPS): A generic risk assessment approach for biological agents notified to the European Food Safety Authority (EFSA). Trends Food Sci Technol. 2010;21(9):425–435. doi:10.1016/j.tifs.2010.07.003. Lew LC, Liong MT. Bioactives from probiotics for dermal health: Functions and benefits. J Appl Microbiol. 2013;114(5):1241–1253. doi:10.1111/jam.12137. Lye HS, Rahmat-Ali GR, Leong MT. Mechanisms of cholesterol removal by Lactobacillus under conditions that mimic the human gastrointestinal tract. Int Dairy J. 2010;20(3):169–175. doi:10.1016/j.idairyj.2009.10.003. Masdea L, Kulik EM, Hauser-Gerspach I, Ramseier AM, Filippi A, Waltimo T. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol. 2012;57(8):1041–1047. doi:10.1016/j.archoralbio.2012.02.011. Matsumoto M, Kibe R, Ooga T, Aiba Y, Sawaki E, Koga Y, et al. Cerebral low-molecular metabolites influenced by intestinal microbiota: A pilot study. Front Syst Neurosci. 2013;7:9. doi:10.3389/fnsys.2013.00009. Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan EE, de Vos WM, et al. Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol. 2005;71(7):4153–4155. doi:10.1128/AEM.71.7.4153-4155.2005. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–1638. doi:10.1126/science.1110591. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414. ILSI Europe. Scientific concepts of functional foods in Europe: Consensus document. Br J Nutr. 1999;81(Suppl 1):1S–27S. Strachan DP, Golding J, Anderson HR. Regional variations in wheezing illness in British children: Effect of migration during early childhood. J Epidemiol Community Health. 1990;44(3):231–236. doi:10.1136/jech.44.3.231. Holt PG, Macaubas C, Prescott SL, Sly PD. Microbial stimulation as an aetiologic factor in atopic disease. Allergy. 1999;54(Suppl 54):12–16. doi:10.1111/j.1398-9995.1999.tb04382.x. Adlerberth I. The establishment of normal intestinal microflora in the newborn infants [PhD Dissertation]. Gothenburg: University of Gothenburg; 1996. Bennet R, Eriksson M, Nord CE, Zetterström R. Suppression of aerobic and anaerobic fecal flora in newborns receiving parenteral gentamicin and ampicillin. Acta Paediatr Scand. 1982;71(4):559–562. doi:10.1111/j.1651-2227.1982.tb09474.x. Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, de Vos WM. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol. 2007;51(2):260–269. doi:10.1111/j.1574 -695X.2007.00306.x. Sepp E, Voor T, Julge K, Lõivukene K, Björkstén B, Mikelsaar M. Is intestinal microbiota bound up with changing lifestyle? In: Mendez-Vilas A, editor. Modern Multi-disciplinary Applied Microbiology: Exploiting Microbes and Their Interactions. Weinheim: Wiley-VCH; 2006. p. 708–712. Björkstén B, Graninger G, Jacobsson Ekman G. New ideas in asthma and allergy research: Creating a multidisciplinary graduate school. J Clin Invest. 2003;112(6):816–820. doi:10.1172/JCI19798. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: Underscoring the importance of viability. J Pediatr Gastroenterol Nutr. 2003;36(2):223–227. doi:10.1097/00005176-200302000-00012. Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol. 2001;32(1):1–7. doi:10.1111/j.1574-695X.2001.tb00526.x. Food and Agriculture Organization (FAO). Guidelines for the evaluation of probiotics in food. 2002. Available from: http://www.who.int/foodsafety/fs_management/e n/probiotic_guidelines.pdf Mercenier A, Lenoir-Wijnkoop I, Sanders ME. Physiological and functional properties of probiotics. Bull Int Dairy Fed. 2008;429:2–6. Rijkers GT, Watzl B, Rabot S, Rafter J, Antoine JM, Haller D, et al. Guidance for assessing the probiotics beneficial effects: How to fill GAP. ILSI Europe Workshop in Association with the International Dairy Federation. Montreux, Switzerland; 2008. Reid G, Kim SO, Kohler GA. Selecting, testing and understanding probiotic microorganisms. FEMS Immunol Med Microbiol. 2006;46(2):149–157. International Journal of Medical and All Body Health Research www.allmedicaljournal.com doi:10.1111/j.1574-695X.2005.00026.x. Lu L, Walker WA. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr. 2001;73(6):1124S–1130S. doi:10.1093/ajcn/73.6.1124S. Attitalla IH, Elhai GA, Gaballa MF, Elzlitni RA, Jhones RC, Abid AADM, et al. Exploring the extended pathogenesis of infectious bronchitis virus strain M41: Insights from expected and novel tissue targets in chicks. Acta Tradit Med. 2024;3(1):19–23. Gaballa MF. Microbial influence on animal health: The role of gut microbiota, dysbiosis, and probiotic interventions. Int J Interdiscip Multidiscip Stud. 2024;12(2):1–20. Attitalla IH, El-Seifat RM, Bufarwa SM, Gaballa MF, Soutiyah MAA, Abdulhafith SA, et al. The role of marine algae as a bioindicator in assessing environmental pollution. J Surv Fish Sci. 2023;10(4S):1837–1869. Alsadi I, Zafir AG, Alati MM, Hamad R, Saleh A, Gaballa MF, et al. Risk analysis of brucellosis in country level Libya. J Vet Sci Res. 2023;8(1):1–5. Akhreim AA, Gaballa MF, Sulaiman G, Attitalla IH. Biofertilizers production and climate changes on environmental prospective applications for some nanoparticles produced from some microbial isolates. Int J Agric Biosci. 2024;13(2):196–203. Gaballa MF. Chromobacterium violaceum strains growth conditions impacting N-Acyl Homoserine Lactones (AHL) production [Master's Thesis]. Tennessee State University; 2017. Alfaytouri NA, Al-Ryani MA, Gaballa MF, Attitalla IH. Vulvovaginal candidiasis in pregnant women. GPH Int J Biol Med Sci. 2024;7(3):35–53. Elyass ME, Gaballa MF, Soutiyah MAA, Abid AADM. Microbiological evaluation and chemical analysis of potable water in Al-Jabal Al-Akhdar. J Environ Sci Public Health. 2024;8(2):45–58. Surendar AP, Palanivel KM, Saravanan S, Gopala-Krishnamurthy R. Detection and characterization of infectious bronchitis virus in desi birds by molecular assay. Int J Curr Microbiol Appl Sci. 2017;6(10):1098– 1102. Khalil MM, Gaballa MF, Sulaiman G, Attitalla IH. Epidemiological assessment of the burden and determinants of methicillin-resistant Staphylococcus aureus (MRSA) infections in wounds. Int J Biol Med Sci. 2024;7(5):39–50. Elhafi GE, Gaballa MF, Attitalla IH, Albakush SA. Determination of aflatoxin levels in groundnuts: A comparative study between domestic and imported seed supplies in Libya. GPH Int J Appl Sci. 2024;7(4):1–7. Elhafi GE, Gaballa MF, Attitalla IH, Albakush SA, Albackoosh MA. Examining the health benefits of olive oil: A review tailored to the Libyan setting. GPH Int J Biol Med Sci. 2024;7(4):14–23. Mahmoud R, Gaballa M, Alsadi I, Saleh A, Abd Alati M, Abid AA. Microbiological evaluation of retail veal meat in the city of Al Bayda, Libya. AlQalam J Med Appl Sci. 2024;8(2):335–340. Khalil MM, Sulaiman G, Gaballa MF, Attitalla IH. Investigation of bacterial flora on mobile phones: A comparative study between healthcare workers and non-healthcare workers. J Microbiol Res. 2024;24(1):1–7. Akhreim AA, Jadhav AU, Gaballa MF, Ahire KD, Abid AAD, Sulaiman G, et al. The contribution of stress-tolerant plant growth-promoting rhizobacteria (PGPR) from abiotic-stressed ecosystems to sustainable plant management: A comprehensive review. Front Microbiol. 2024;15:1023456. Fouad I, Alamami H, Gaballa MF, Selem E. Production and characterization of Aspergillus terreus inulinase, using a by-product of green asparagus (Asparagus officinalis L.). Cuestiones Fisioter. 2025;54(5):847–880. Alhudiri IM, Gaballa MF, Ebrahim FO, Ahire KD, Eltaib FI, Attitalla IH, et al. Post-acute COVID-19 pathophysiology: Cellular stress responses, immune dysregulation, and biochemical signatures in recovery phase. Cell Physiol Biochem. 2025;59(4):485–495. Gaballa MF, Soutiyah MAA, Abid AAD, Attitalla IH. Distribution, abundance, and environmental responses of Actinobacteria in rhizospheric and bulk soils of Al-Haniya, Libya. Acta Biol Forum. 2025;12(3):45–58. Attitalla IH, Gaballa MF, ALraaydi NS, Abid AAD. Exploring the antimicrobial capabilities of date palm seed essential oil. Microbiol Arch. 2024;8(2):112– 120.